Literature DB >> 10448363

Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group.

C A Ison1, I M Martin.   

Abstract

OBJECTIVES: To establish the in vitro susceptibility of gonococci isolated in the London area to antibiotics in current therapeutic use and to establish a sentinel surveillance system for monitoring trends in antibiotic resistant gonorrhoea in London.
METHODS: Isolates of Neisseria gonorrhoeae from consecutive patients attending genitourinary medicine clinics at 10 hospitals in the London area were collected over a 3 month period, May to July 1997. The susceptibility to penicillin, ciprofloxacin, tetracycline, and spectinomycin was determined for each isolate. Isolates exhibiting either plasmid or chromosomally mediated resistance were additionally tested for susceptibility to agents used as alternative treatments including azithromycin, ceftriazone, and ofloxacin. The resistant isolates were also tested for plasmid profiles (penicillinase producing N gonorrhoeae, PPNG), type of tetM determinant (tetracycline resistant N gonorrhoeae, TRNG), and presence of gyrA and parC mutations (quinolone resistant N gonorrhoeae, QRNG).
RESULTS: A total of 1133 isolates were collected which represents > 95% of the total gonococci isolated in the 3 months. Plasmid mediated resistance was exhibited by 48 (4.2%) isolates; six (0.5%) were PPNG, 15 (1.3%) were PP/TRNG, and 27 (2.4%) were TRNG. The majority of PPNG (18 of 20 tested) carried the 3.2 MDa penicillinase plasmid whereas the two types of tetM determinant were more evenly distributed. High level resistance to ciprofloxacin was detected in four (0.4%) isolates and double mutations were found in the quinolone resistance determining region (QRDR) of the gyrA gene in three QRNG with MICs of 16 mg/l and a single mutation in one isolate with a MIC of 1 mg/l to ciprofloxacin. No parC mutations were found. Of the remaining 1081 isolates, 86 (8.0%) were chromosomally mediated resistant N gonorrhoeae (CMRNG).
CONCLUSIONS: A unique collection of gonococcal isolates has been established which can be used as a baseline for surveillance of susceptibility to antibiotics and for epidemiological purposes.

Entities:  

Mesh:

Year:  1999        PMID: 10448363      PMCID: PMC1758195          DOI: 10.1136/sti.75.2.107

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  24 in total

1.  Rectal gonorrhoea and unsafe sex.

Authors:  H Young; A Moyes; J G McKenna; A McMillan
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

2.  Surveillance of antibiotic resistance in clinical isolates of Neisseria gonorrhoeae.

Authors:  C A Ison; N S Branley; K Kirtland; C S Easmon
Journal:  BMJ       Date:  1991-11-23

3.  National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project.

Authors:  S K Schwarcz; J M Zenilman; D Schnell; J S Knapp; E W Hook; S Thompson; F N Judson; K K Holmes
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

4.  Penicillinase-producing Neisseria gonorrhoeae--a retrospective.

Authors:  W M McCormack
Journal:  N Engl J Med       Date:  1982-08-12       Impact factor: 91.245

5.  Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission.

Authors:  J A McCutchan; M W Adler; J R Berrie
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31

6.  Detection of the tetM determinant in Neisseria gonorrhoeae.

Authors:  C A Ison; N Tekki; M J Gill
Journal:  Sex Transm Dis       Date:  1993 Nov-Dec       Impact factor: 2.830

7.  Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales.

Authors:  B G Evans; M A Catchpole; J Heptonstall; J Y Mortimer; C A McCarrigle; A G Nicoll; P Waight; O N Gill; A V Swan
Journal:  BMJ       Date:  1993-02-13

8.  Nucleotide sequences of the tet(M) genes from the American and Dutch type tetracycline resistance plasmids of Neisseria gonorrhoeae.

Authors:  D M Gascoyne-Binzi; J Heritage; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  1993-11       Impact factor: 5.790

9.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial.

Authors:  H Grosskurth; F Mosha; J Todd; E Mwijarubi; A Klokke; K Senkoro; P Mayaud; J Changalucha; A Nicoll; G ka-Gina
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

10.  Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men.

Authors:  K J Craib; D R Meddings; S A Strathdee; R S Hogg; J S Montaner; M V O'Shaughnessy; M T Schechter
Journal:  Genitourin Med       Date:  1995-06
View more
  3 in total

1.  Laboratory diagnosis of Neisseria gonorrhoeae in St Petersburg, Russia: inventory, performance characteristics and recommended optimisations.

Authors:  M Unemo; A Savicheva; O Budilovskaya; E Sokolovsky; M Larsson; M Domeika
Journal:  Sex Transm Infect       Date:  2006-02       Impact factor: 3.519

2.  Antimicrobial Susceptibility Testing Patterns of Neisseria gonorrhoeae from Patients Attending Sexually Transmitted Infections Clinics in Six Regions in Tanzania.

Authors:  Said Aboud; Simon N Buhalata; Onduru G Onduru; Mercy G Chiduo; Gideon P Kwesigabo; Stephen E Mshana; Alphaxard M Manjurano; Mansuet M Temu; Coleman Kishamawe; John M Changalucha
Journal:  Trop Med Infect Dis       Date:  2022-06-02

3.  Gonorrhoea in London: usefulness of first line therapies.

Authors:  C A Ison; I M C Martin
Journal:  Sex Transm Infect       Date:  2002-04       Impact factor: 3.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.